Clearmind Medicine (CMND) EBITDA (2016 - 2026)
Clearmind Medicine (CMND) EBITDA from Apr 30, 2016 to Jan 31, 2026. The TTM Clearmind Medicine (CMND) EBITDA is -$5.36M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Clearmind Medicine (CMND) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +4.97% |
| 3 Years TTM | -3.12% |
| 5 Years TTM | +87.12% |
Annual EBITDA change of Clearmind Medicine (CMND)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$2.66M | +0.21% |
| 2025 | -$2.66M | -44.54% |
| 2024 | -$4.79M | -43.48% |
| 2023 | -$8.47M | +18.31% |
| 2022 | -$7.16M | +142.86% |
| 2021 | -$2.95M | +1607.32% |
| 2020 | -$173K | +106.71% |
| 2019 | -$84K | -56.03% |
| 2018 | -$190K | +2349.52% |
| 2017 | -$7.76K | N/A |
| 2016 | $0 | N/A |
| 2015 | $0 | N/A |
| 2014 | $0 | N/A |
Comparison Clearmind Medicine (CMND) five years EBITDA CAGR with competitors
Clearmind Medicine (CMND) five years EBITDA CAGR is 87.64%.